Education
About Us
Working with TipRanks
Follow Us
CellaVision AB (SE:CEVI)
:CEVI
CEVI Stock Chart & Stats
kr153.20
-kr3.60(-2.10%)
At close: 4:00 PM EST
kr153.20
-kr3.60(-2.10%)
Day’s Range― - ―
52-Week Rangekr147.80 - kr232.50
Previous CloseN/A
Volume5.79K
Average Volume (3M)36.08K
Market Cap
$3.86B
Enterprise Valuekr3.99B
Total Cash (Recent Filing)$158.67M
Total Debt (Recent Filing)$27.26M
Price to Earnings (P/E)25.5
Beta0.82
Next Earnings
Feb 05, 2026EPS Estimate
1.37Last Dividend Ex-Date
May 07, 2025Dividend Yield1.63%
Share Statistics
EPS (TTM)1.30
Shares Outstanding23,851,547
10 Day Avg. Volume30,505
30 Day Avg. Volume36,083
Financial Highlights & Ratios
PEG Ratio4.57
Price to Book (P/B)6.36
Price to Sales (P/S)7.17
P/FCF Ratio42.98
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue5.32
Enterprise Value/Gross Profit7.70
Enterprise Value/Ebitda17.33
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CellaVision AB News
CEVI FAQ
What was CellaVision AB’s price range in the past 12 months?
CellaVision AB lowest stock price was kr147.80 and its highest was kr232.50 in the past 12 months.
What is CellaVision AB’s market cap?
CellaVision AB’s market cap is $3.86B.
When is CellaVision AB’s upcoming earnings report date?
CellaVision AB’s upcoming earnings report date is Feb 05, 2026 which is in 52 days.
How were CellaVision AB’s earnings last quarter?
CellaVision AB released its earnings results on Nov 06, 2025. The company reported kr1.305 earnings per share for the quarter, beating the consensus estimate of kr1.063 by kr0.242.
Is CellaVision AB overvalued?
According to Wall Street analysts CellaVision AB’s price is currently Overvalued.
Does CellaVision AB pay dividends?
CellaVision AB pays a Annually dividend of kr2.5 which represents an annual dividend yield of 1.63%. See more information on CellaVision AB dividends here
What is CellaVision AB’s EPS estimate?
CellaVision AB’s EPS estimate is 1.37.
How many shares outstanding does CellaVision AB have?
CellaVision AB has 23,851,547 shares outstanding.
What happened to CellaVision AB’s price movement after its last earnings report?
CellaVision AB reported an EPS of kr1.305 in its last earnings report, beating expectations of kr1.063. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of CellaVision AB?
Currently, no hedge funds are holding shares in SE:CEVI
Company Description
CellaVision AB
CellaVision AB (CEVI) is a Swedish company specializing in the development and marketing of innovative digital solutions for the field of medical diagnostics, particularly in hematology. The company offers advanced image analysis systems that assist laboratories in the automated analysis of blood samples, enhancing the efficiency, accuracy, and consistency of diagnostic processes. CellaVision's products are widely used in clinical laboratories and hospitals, contributing to improved patient care and operational efficiency.
CEVI Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with several strategic advancements and organic growth offset by regional performance issues and currency headwinds. The company's strategic initiatives and innovation efforts show potential for future growth, but current challenges in certain markets and financial metrics present areas of concern.View all SE:CEVI earnings summariesTechnical Analysis
BICO Group AB Class B
―
Senzime AB
―
Xvivo Perfusion AB
―
C-Rad AB Class B
―
Sedana Medical AB
―
Options Prices
Currently, No data available
---